235 related articles for article (PubMed ID: 18316552)
1. Enhanced expression of RAD51 associating protein-1 is involved in the growth of intrahepatic cholangiocarcinoma cells.
Obama K; Satoh S; Hamamoto R; Sakai Y; Nakamura Y; Furukawa Y
Clin Cancer Res; 2008 Mar; 14(5):1333-9. PubMed ID: 18316552
[TBL] [Abstract][Full Text] [Related]
2. Comparison of gene expression profiles between Opisthorchis viverrini and non-Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma.
Jinawath N; Chamgramol Y; Furukawa Y; Obama K; Tsunoda T; Sripa B; Pairojkul C; Nakamura Y
Hepatology; 2006 Oct; 44(4):1025-38. PubMed ID: 17006947
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma.
Obama K; Ura K; Li M; Katagiri T; Tsunoda T; Nomura A; Satoh S; Nakamura Y; Furukawa Y
Hepatology; 2005 Jun; 41(6):1339-48. PubMed ID: 15880566
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma.
Nishino R; Honda M; Yamashita T; Takatori H; Minato H; Zen Y; Sasaki M; Takamura H; Horimoto K; Ohta T; Nakanuma Y; Kaneko S
J Hepatol; 2008 Aug; 49(2):207-16. PubMed ID: 18490072
[TBL] [Abstract][Full Text] [Related]
5. Enhanced RASGEF1A expression is involved in the growth and migration of intrahepatic cholangiocarcinoma.
Ura K; Obama K; Satoh S; Sakai Y; Nakamura Y; Furukawa Y
Clin Cancer Res; 2006 Nov; 12(22):6611-6. PubMed ID: 17121879
[TBL] [Abstract][Full Text] [Related]
6. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M
Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma.
Sugimachi K; Taguchi K; Aishima S; Tanaka S; Shimada M; Kajiyama K; Sugimachi K; Tsuneyoshi M
Mod Pathol; 2001 Sep; 14(9):900-5. PubMed ID: 11557787
[TBL] [Abstract][Full Text] [Related]
8. Human REG I gene is up-regulated in intrahepatic cholangiocarcinoma and its precursor lesions.
Harada K; Zen Y; Kanemori Y; Chen TC; Chen MF; Yeh TS; Jan YY; Masuda S; Nimura Y; Takasawa S; Okamoto H; Nakanuma Y
Hepatology; 2001 May; 33(5):1036-42. PubMed ID: 11343228
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of PSF2, a member of the GINS multiprotein complex, in intrahepatic cholangiocarcinoma.
Obama K; Ura K; Satoh S; Nakamura Y; Furukawa Y
Oncol Rep; 2005 Sep; 14(3):701-6. PubMed ID: 16077978
[TBL] [Abstract][Full Text] [Related]
10. Anatomic and molecular pathology of intrahepatic cholangiocarcinoma.
Nakanuma Y; Harada K; Ishikawa A; Zen Y; Sasaki M
J Hepatobiliary Pancreat Surg; 2003; 10(4):265-81. PubMed ID: 14598145
[TBL] [Abstract][Full Text] [Related]
11. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
[TBL] [Abstract][Full Text] [Related]
12. Relationship between pancreatic secretory trypsin inhibitor and early recurrence of intrahepatic cholangiocarcinoma following surgical resection.
Tonouchi A; Ohtsuka M; Ito H; Kimura F; Shimizu H; Kato M; Nimura Y; Iwase K; Hiwasa T; Seki N; Takiguchi M; Miyazaki M
Am J Gastroenterol; 2006 Jul; 101(7):1601-10. PubMed ID: 16863567
[TBL] [Abstract][Full Text] [Related]
13. The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma.
Park BK; Paik YH; Park JY; Park KH; Bang S; Park SW; Chung JB; Park YN; Song SY
Am J Clin Oncol; 2006 Apr; 29(2):138-42. PubMed ID: 16601431
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus core upregulates the methylation status of the RASSF1A promoter through regulation of SMYD3 in hilar cholangiocarcinoma cells.
Guo N; Chen R; Li Z; Liu Y; Cheng D; Zhou Q; Zhou J; Lin Q
Acta Biochim Biophys Sin (Shanghai); 2011 May; 43(5):354-61. PubMed ID: 21450690
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinoma.
Maeda T; Taguchi K; Aishima S; Shimada M; Hintz D; Larusso N; Gores G; Tsuneyoshi M; Sugimachi K; Wands JR; de la Monte SM
Cancer Detect Prev; 2004; 28(5):313-8. PubMed ID: 15542253
[TBL] [Abstract][Full Text] [Related]
16. Allelotype analysis of intrahepatic cholangiocarcinoma.
Kang YK; Kim YI; Kim WH
Mod Pathol; 2000 Jun; 13(6):627-31. PubMed ID: 10874666
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance.
Shimonishi T; Isse K; Shibata F; Aburatani I; Tsuneyama K; Sabit H; Harada K; Miyazaki K; Nakanuma Y
Hepatology; 2000 Oct; 32(4 Pt 1):761-9. PubMed ID: 11003620
[TBL] [Abstract][Full Text] [Related]
18. L1 cell adhesion molecule is a novel therapeutic target in intrahepatic cholangiocarcinoma.
Min JK; Kim JM; Li S; Lee JW; Yoon H; Ryu CJ; Jeon SH; Lee JH; Kim JY; Yoon HK; Lee YK; Kim BH; Son YS; Choi HS; Lim NK; Kim DG; Hong HJ
Clin Cancer Res; 2010 Jul; 16(14):3571-80. PubMed ID: 20501614
[TBL] [Abstract][Full Text] [Related]
19. Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma.
Kang YK; Kim WH; Lee HW; Lee HK; Kim YI
Lab Invest; 1999 Apr; 79(4):477-83. PubMed ID: 10212000
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Wnt signaling induces cell apoptosis and suppresses cell proliferation in cholangiocarcinoma cells.
Zhang KS; Zhou Q; Wang YF; Liang LJ
Oncol Rep; 2013 Sep; 30(3):1430-8. PubMed ID: 23799613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
